McKesson Corporation
McKesson Corporation
Your view on MCK
Overview
What the company does, where it operates, and who runs it.
About McKesson Corporation
- Industry
- Medical - Distribution
- Sector
- Healthcare
- CEO
- Brian S. Tyler
- Headquarters
- 6555 State Highway 161, Irving, TX, US
- Industry
- Medical - Distribution
- Sector
- Healthcare
- CEO
- Brian S. Tyler
- Headquarters
- 6555 State Highway 161, Irving, TX, US
McKesson Corporation provides healthcare services in the United States and internationally.
It operates through four segments: U.S. Pharmaceutical, International, Medical-Surgical Solutions, and Prescription Technology Solutions (RxTS). The U.S. Pharmaceutical segment distributes branded, generic, specialty, biosimilar, and over-the-counter pharmaceutical drugs and other healthcare-related products.
This segment also provides practice management, technology, clinical support, and business solutions to community-based oncology and other specialty practices; and consulting, outsourcing, technological, and other services, as well as sells financial, operational, and clinical solutions to pharmacies.
The International segment offers distribution and services to wholesale, institutional, and retail customers in 13 European countries and Canada. The Medical-Surgical Solutions segment provides medical-surgical supply distribution, logistics, and other services to healthcare providers.
The RxTS segment serves biopharma and life sciences partners and patients to address medication challenges for patients throughout their journeys; connects pharmacies, providers, payers, and biopharma companies to deliver innovative access and adherence solutions; and provides third-party logistics and wholesale distribution support solutions.
McKesson Corporation was founded in 1833 and is headquartered in Irving, Texas.
Stock Data
Price chart, volume, and trading data.
Fair Value
What FRC thinks it is worth vs. the current price.
FRC's fair value estimate for McKesson Corporation, and the rating behind it. MCK last traded at $992.87, 26.4× trailing earnings — the estimate is read against that market price. FRC analysts run the firm's valuation model across the companies on this platform to estimate what each one is worth, rather than republishing a consensus average. Shows the current estimate, our rating, and when it was last revised. A free account covers 7 company valuations a month; a paid subscription is unlimited.
Financial Ratios
Profitability, returns, valuation, and leverage ratios.
Valuation, profitability, liquidity and leverage ratios for McKesson Corporation. Starting points for McKesson Corporation: P/E 26.4, EPS $38.69, beta 0.30 — an Medical - Distribution name. P/E, P/B, EV/EBITDA, margins, return on equity, current ratio and debt coverage, each shown against the company's own history.
Dividend Analysis
Yield, payout ratio, and dividend coverage metrics.
Dividend history, yield and payout sustainability for McKesson Corporation. McKesson Corporation paid $3.40 per share over the last year — a 0.3% yield at the current $992.87 price. Per-share payments, yield over time, payout ratio and growth streak, with coverage measured against free cash flow.
Earnings Analysis
EPS history, beat rate, and upcoming earnings reports.
Reported vs. expected earnings history for McKesson Corporation. Trailing twelve-month EPS for McKesson Corporation stands at $38.69. EPS surprises by quarter, revenue against estimates, and the upcoming reporting date.
Financial Statements
Income statement, balance sheet, and cash flow statements.
Income statement, balance sheet and cash flow history for McKesson Corporation. McKesson Corporation has reported as a listed company since 1994. Annual and quarterly filings with period-over-period comparison, so you can trace how revenue, margins and cash generation have moved.
Comparables
List of peer companies in the same industry.
McKesson Corporation valued side by side against its closest peers. McKesson Corporation is measured against Medical - Distribution peers within the Healthcare sector. Peer-relative multiples and operating metrics, so the valuation is read in the context of its own sector rather than in isolation.
Institutional Ownership
PremiumWhich funds and firms own the stock.
Which institutions hold McKesson Corporation, and how their positions are changing. At a $115.76B market value, institutional positions materially move McKesson Corporation's register. Top holders, position sizes, and quarter-over-quarter accumulation or distribution from regulatory filings. Included with FRC Premium.
Insider Trading
PremiumRecent buying and selling by company executives.
Buying and selling by McKesson Corporation executives and directors. Shares of McKesson Corporation have traded between $558.13 and $867.63 over the past 52 weeks — context for the timing of the transactions below. Insider transactions as disclosed to regulators, with role, size and date — the clearest read on how the people running the company are positioned. Included with FRC Premium.
Senate Trading
PremiumU.S. Senator disclosures filed under the STOCK Act.
U.S. Senate disclosures naming McKesson Corporation. McKesson Corporation is a $115.76B Healthcare company. Senators' reported transactions in this security, alongside the fundamentals — a signal most research platforms leave out entirely. Included with FRC Premium.
House Trading
PremiumU.S. Representative disclosures filed under the STOCK Act.
U.S. House of Representatives disclosures naming McKesson Corporation. Representatives' reported transactions in this security, shown next to the company's fundamentals. Included with FRC Premium.
News
Latest headlines and market coverage.
Latest headlines and company announcements for McKesson Corporation. Coverage tracks McKesson Corporation within Medical - Distribution (Healthcare). Press releases and market coverage, newest first.
Comments
Comments and replies from FRC members about this company.